+36.1%
MRNA vs LEN
-27.3%
+63.4%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | LEN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | +2.2% | +3.2% | +4.2% |
| 7D | -1.1% | -4.8% | +3.7% | +1.5% |
| 30D | +126.1% | -6.6% | +132.7% | +137.0% |
| 3M | +190.0% | -15.7% | +205.7% | +214.6% |
| 6M | +157.2% | -16.6% | +173.9% | +179.5% |
| YTD | +388.2% | -21.3% | +409.5% | +436.8% |
| 1Y | +467.0% | -42.0% | +509.1% | +606.1% |
| 3Y | +36.1% | -27.9% | +64.0% | +42.5% |
| All | +36.1% | -27.3% | +63.4% | +42.5% |
Cumulative growth
Daily Returns
Daily percentage return beside LEN.
Daily Out/Under-Performance
Portfolio return minus LEN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LEN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded LEN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling